Monoclonal Antibody News and Research

RSS
Monoclonal antibodies (MAbs) are produced from a single B cell clone and can bind to a single type of antigen binding site. MAbs are homogenous antibodies that cannot form lattices with monomeric proteins as they can bind to only a single epitope on the antigen. Developed in the 1970s, MAbs can be produced against any given substance. Thus they can be used to detect and purify any substance of interest. This has made MAbs a powerful tool of molecular biology, biochemistry, and medicine.
Synergistic multi-antibody cocktail protects against SARS-CoV-2 in animal model

Synergistic multi-antibody cocktail protects against SARS-CoV-2 in animal model

Clinical trial to test personalized treatment for severe asthma caused by a specific mutation

Clinical trial to test personalized treatment for severe asthma caused by a specific mutation

Combination of investigational therapeutic and chemotherapy shows promise for AML treatment

Combination of investigational therapeutic and chemotherapy shows promise for AML treatment

Researchers examine efficacy of CT-P59 monoclonal antibody against SARS-CoV-2 Brazil variant

Researchers examine efficacy of CT-P59 monoclonal antibody against SARS-CoV-2 Brazil variant

Neutralizing aptamers block SARS-CoV-2 infection in vitro

Neutralizing aptamers block SARS-CoV-2 infection in vitro

Novel monoclonal antibody could pave way for future COVID-19 treatments and vaccines

Novel monoclonal antibody could pave way for future COVID-19 treatments and vaccines

Kids misusing soft drinks to corrupt SARS-CoV-2 tests

Kids misusing soft drinks to corrupt SARS-CoV-2 tests

B.1.427/B.1.429 variant of SARS-CoV-2 evades neutralization via disulfide bond rearrangement

B.1.427/B.1.429 variant of SARS-CoV-2 evades neutralization via disulfide bond rearrangement

Doctors advise against off-label use of new Alzheimer's medicine for cerebral amyloid angiopathy

Doctors advise against off-label use of new Alzheimer's medicine for cerebral amyloid angiopathy

Study says mRNA COVID vaccines are effective against Lambda variant

Study says mRNA COVID vaccines are effective against Lambda variant

Scientists identify breakthrough cases of SARS-CoV-2’s delta variant in fully vaccinated individuals

Scientists identify breakthrough cases of SARS-CoV-2’s delta variant in fully vaccinated individuals

COVID-19 vaccines are effective in 94% of cancer patients, shows study

COVID-19 vaccines are effective in 94% of cancer patients, shows study

Moderna's COVID vaccine effective against emerging variants including Delta

Moderna's COVID vaccine effective against emerging variants including Delta

Could polio vaccines induce cross-reactive antibodies that target SARS-CoV-2?

Could polio vaccines induce cross-reactive antibodies that target SARS-CoV-2?

Do the Moderna and Pfizer COVID-19 vaccines elicit different antibody responses?

Do the Moderna and Pfizer COVID-19 vaccines elicit different antibody responses?

Dual-antibody combination therapies effective against SARS-CoV-2 variants in animal study

Dual-antibody combination therapies effective against SARS-CoV-2 variants in animal study

A World First: sequencing polyclonal antibodies using only proteomics

A World First: sequencing polyclonal antibodies using only proteomics

Can convalescent plasma therapy improve COVID-19 outcomes in patients with hematologic cancers?

Can convalescent plasma therapy improve COVID-19 outcomes in patients with hematologic cancers?

Antibody combination REGEN-COV prevents symptomatic disease following SARS-CoV-2 infection

Antibody combination REGEN-COV prevents symptomatic disease following SARS-CoV-2 infection

Increased viral replication and shedding in nonhuman primates carrying SARS-CoV-2 B.1.1.7 variant

Increased viral replication and shedding in nonhuman primates carrying SARS-CoV-2 B.1.1.7 variant